CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 407 enrolled
Drug / intervention
LMWH +2 moredrug
Likely dose
LMWH 40 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03044574
NCT03044574N/ACompleted

Trial to Assess the Effectiveness of Intermittent Pneumatic Compression in the Prevention of Postoperative Venous Thromboembolism in Surgical Patients at Extremely High Risk

Pirogov Russian National Research Medical University·interventional·Posted Feb 7, 2017·Updated Feb 4, 2021

In Brief

A clinical study evaluating SCD, GCS, and 1 other intervention for Venous Thromboembolism and Venous Thrombosis. Completed, enrolled 407 participants across 2 sites.

Detailed Summary

The aim of the study is to evaluate efficacy and safety of venous thromboembolism prophylaxis by the combination of graduated compression stockings (GCS), standard doses of low-molecular-weight heparins (LMWH) and sequential compression device (SCD) in the mixed group of surgical patients at high and extremely high risk for venous thromboembolism.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesRussia
CollaboratorsMedtronic

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 7, 2017
Enrollment StartFeb 1, 2017
Primary CompletionSep 30, 2018
Study CompletionDec 31, 2018
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 9.4 years ago

Interventions

SCDdevice

Intermittent pneumatic compression (IPC) with Kendall SCD™ Sequential Compression System 700 used continuously when the patient is in bed with 6-hours night interval free of compression: from 0 a.m. to 6 a.m. In the ICU SCD used continuously all day, and in surgery department - all time of bed resting. SCD used until discharge.

GCSdevice

Thigh-length graduated compression stockings with pressure of 18-21 mm. Hg at the ankle used all the time until discharge plus one month after discharge

LMWHdrug

LMWH enoxaparin (Clexane) 40 mg once a day subcutaneously started on 1st or 2-5th postoperative day according to the bleeding risk and used until discharge.